Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Endosc. Oct 16, 2022; 14(10): 597-607
Published online Oct 16, 2022. doi: 10.4253/wjge.v14.i10.597
Figure 1
Figure 1 Survival estimate curve along with population at risk table. A: Estimated probability of not developing gastric intestinal metaplasia at a respective time interval after baseline without gastric intestinal metaplasia (GIM); B: The estimated probability of not developing gastric intestinal metaplasia in different ethnicities/races at a respective time interval after baseline without GIM; C: The estimated probability of not developing gastric intestinal metaplasia in different age groups at a respective time interval after baseline without GIM; D: The estimated probability of not developing gastric intestinal metaplasia in gastritis compared to no gastritis at a respective time interval after baseline without GIM. GIM: Gastric intestinal metaplasia.

  • Citation: Ahmad AI, Lee A, Caplan C, Wikholm C, Pothoulakis I, Almothafer Z, Raval N, Marshall S, Mishra A, Hodgins N, Kang IG, Chang RK, Dailey Z, Daneshmand A, Kapadia A, Oh JH, Rodriguez B, Sehgal A, Sweeney M, Swisher CB, Childers DF, O'Connor C, Sequeira LM, Cho W. Gastric intestinal metaplasia development in African American predominant United States population. World J Gastrointest Endosc 2022; 14(10): 597-607
  • URL: https://www.wjgnet.com/1948-5190/full/v14/i10/597.htm
  • DOI: https://dx.doi.org/10.4253/wjge.v14.i10.597